Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: completion (210), fruition (7), end result (477), end (820), execution (13), realization (21)

PIS COVID-19 immsup adults V2.1

Description: Participant Information Study Title: Coronavirus infection in immunosuppressed children and adults. Chief Inve
Url: /Media/Southampton-Clinical-Research/COVID-19/ImmunoCOVID/PIS-COVID-19-immsup-adults-V2.1.pdf

ImmunoCOVID19 info for parents or carers and children aged 16-17

Description: Participant Information for parents/carers and children aged 16-17 years Study Title: Coronavirus infection in p
Url: /Media/Southampton-Clinical-Research/Downloads/Immunocovid/ImmunoCOVID19-info-for-parents-or-carers-and-children-aged-16-17.pdf

PIS COVID-19 immsup child - over 16 yrs and parents V1.6

Description: Participant Information for parents/carers and children aged 16-17 years Study Title: Coronavirus infection in
Url: /Media/Southampton-Clinical-Research/COVID-19/PIS-COVID-19-immsup-child-over-16-yrs-and-parents-V1.6.pdf

Flexible sigmoidoscopy (F1) aftercare advice - patient information

Description: This factsheet explains what to expect after having a flexible sigmoidoscopy.
Url: /Media/UHS-website-2019/Patientinformation/Endoscopy/Flexible-sigmoidoscopy-F1-aftercare-advice-680-PIL.pdf

Cemiplimab

Description: Chemotherapy Protocol SKIN CANCER Cemiplimab (350mg) Regimen  Skin – Cemiplimab (350mg) Indication  Metast
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Cemiplimab.pdf

Guide to the Mental Capacity Act - patient information

Description: This leaflet provides an overview of the Mental Capacity Act 2005.
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Guide-to-the-Mental-Capacity-Act-2865-PIL.pdf

Cytarabine(SC)-Venetoclax

Description: Chemotherapy Protocol Acute Myeloid Leukaemia CYTARABINE (SC) - VENETOCLAX Regimen  AML – Cytarabine (SC
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/CytarabineSC-Venetoclax.pdf

Ipilimumab(1mg/kg)-Nivolumab(3mg/kg)

Description: Chemotherapy Protocol RENAL CANCER IPILIMUMAB (1mg/kg)-NIVOLUMAB(3mg/kg) Regimen • Renal – Ipilimumab (1mg/kg)-Nivolumab (3mg/kg) Indication • Ipilimumab in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Ipilimumab1mgkg-Nivolumab3mgkg.pdf

InP-MATRix

Description: Chemotherapy Protocol LYMPHOMA MATRix – CYTARABINE-METHOTREXATE-RITUXIMAB-THIOTEPA Inpatient Regimen Regimen • Lymphoma – InP-MATRix – Cyt
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-MATRix.pdf

InP-Ifosfamide-Liposomal Doxorubicin (Caelyx) v1

Description: Chemotherapy Protocol SARCOMA IFOSFAMIDE-LIPOSOMAL DOXORUBICIN (Caelyx) In-Patient Regimen Please note this
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Ifosfamide-Liposomal-Doxorubicin-Caelyx-v1.pdf

81 to 90 of 162

Previous … 7 8 9 10 11 … Next